Literature DB >> 9150173

Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

S A Gayther, P Harrington, P Russell, G Kharkevich, R F Garkavtseva, B A Ponder.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9150173      PMCID： PMC1712436     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  18 in total

1.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

2.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

3.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

4.  Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21.

Authors:  E Steichen-Gersdorf; H H Gallion; D Ford; C Girodet; D F Easton; R A DiCioccio; G Evans; M A Ponder; C Pye; S Mazoyer
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

5.  Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.

Authors:  C M Phelan; T R Rebbeck; B L Weber; P Devilee; M H Ruttledge; H T Lynch; G M Lenoir; M R Stratton; D F Easton; B A Ponder; L Cannon-Albright; C Larsson; D E Goldgar; S A Narod
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

6.  Growth retardation and tumour inhibition by BRCA1.

Authors:  J T Holt; M E Thompson; C Szabo; C Robinson-Benion; C L Arteaga; M C King; R A Jensen
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

7.  Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

Authors:  S L Neuhausen; S Mazoyer; L Friedman; M Stratton; K Offit; A Caligo; G Tomlinson; L Cannon-Albright; T Bishop; D Kelsell; E Solomon; B Weber; F Couch; J Struewing; P Tonin; F Durocher; S Narod; M H Skolnick; G Lenoir; O Serova; B Ponder; D Stoppa-Lyonnet; D Easton; M C King; D E Goldgar
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

8.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

9.  Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

Authors:  M G FitzGerald; D J MacDonald; M Krainer; I Hoover; E O'Neil; H Unsal; S Silva-Arrieto; D M Finkelstein; P Beer-Romero; C Englert; D C Sgroi; B L Smith; J W Younger; J E Garber; R B Duda; K A Mayzel; K J Isselbacher; S H Friend; D A Haber
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

10.  Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

Authors:  S A Gayther; W Warren; S Mazoyer; P A Russell; P A Harrington; M Chiano; S Seal; R Hamoudi; E J van Rensburg; A M Dunning; R Love; G Evans; D Easton; D Clayton; M R Stratton; B A Ponder
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330
View more
  35 in total

1.  Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer.

Authors:  P de los Rios; E Jack; G Kuperstein; H Lynch; J Lubinski; S A Narod
Journal:  Am J Hum Genet       Date:  2001-02       Impact factor: 11.025

2.  Frequencies of single-nucleotide polymorphisms and mutations in the BRCA1 gene in patients with hereditary breast or ovarian cancer.

Authors:  A V Karpukhin; N I Pospekhova; L N Lubchenko; A N Loginova; E V Khomich; A V Budilov; A S Sergeev; V M Zakhar'ev; R F Gar'kavtseva; E K Ginter
Journal:  Dokl Biol Sci       Date:  2002 Mar-Apr

3.  BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.

Authors:  Danièle Muller; Catherine Bonaiti-Pellié; Joseph Abecassis; Dominique Stoppa-Lyonnet; Jean-Pierre Fricker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

4.  Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.

Authors:  Hélène Vézina; Francine Durocher; Martine Dumont; Louis Houde; Csilla Szabo; Martine Tranchant; Jocelyne Chiquette; Marie Plante; Rachel Laframboise; Jean Lépine; Heli Nevanlinna; Dominique Stoppa-Lyonnet; David Goldgar; Peter Bridge; Jacques Simard
Journal:  Hum Genet       Date:  2005-05-10       Impact factor: 4.132

5.  Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.

Authors:  Sherry I Brandt-Rauf; Victoria H Raveis; Nathan F Drummond; Jill A Conte; Sheila M Rothman
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

6.  The 4154delA mutation carriers in the BRCA1 gene share a common ancestry.

Authors:  Silvija Ozolina; Olga Sinicka; Eriks Jankevics; Inna Inashkina; Jan Lubinski; Bohdan Gorski; Jacek Gronwald; Tatyana Nasedkina; Olga Fedorova; Ludmila Lyubchenko; Laima Tihomirova
Journal:  Fam Cancer       Date:  2008-12-09       Impact factor: 2.375

7.  Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

Authors:  S J Ramus; Z Kote-Jarai; L S Friedman; M van der Looij; S A Gayther; B Csokay; B A Ponder; E Olah
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

8.  Population genetics of BRCA1 and BRCA2.

Authors:  C I Szabo; M C King
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

9.  Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Authors:  P N Tonin; A M Mes-Masson; P A Futreal; K Morgan; M Mahon; W D Foulkes; D E Cole; D Provencher; P Ghadirian; S A Narod
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

10.  BRCA1 4153delA founder mutation in Russian ovarian cancer patients.

Authors:  Nadezhda Yu Krylova; Oksana S Lobeiko; Anna P Sokolenko; Aglaya G Iyevleva; Maxim E Rozanov; Natalia V Mitiushkina; Madina M Gergova; Tatiana V Porhanova; Adel F Urmancheyeva; Sergey Ya Maximov; Alexandr V Togo; Evgeny N Imyanitov
Journal:  Hered Cancer Clin Pract       Date:  2006-09-15       Impact factor: 2.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.